Trial Profile
A Prospective, Double-Blind, Randomized, Parallel trial to assess Effects of Dapagliflozin on Diabetic Macular Edema
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 20 Jul 2017
Price :
$35
*
At a glance
- Drugs Dapagliflozin (Primary)
- Indications Diabetic macular oedema
- Focus Therapeutic Use
- 20 Jul 2017 New trial record
- 13 Jun 2017 Results presented at the 77th Annual Scientific Sessions of the American Diabetes Association